Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.

Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Abstract Text:

    d weintraubD Weintraub,r buchsbaumR Buchsbaum,s r resorS R Resor,l j hirschL J Hirsch,

    OBJECTIVE: Psychiatric/behavioral side effects (PSEs) are common in patients taking antiepileptic drugs (AEDs). The objective of the study described here was to compare the PSE profiles of the newer AEDs. METHODS: We examined the charts of 1394 adult outpatients seen at the Columbia Comprehensive Epilepsy Center who had taken one of the newer AEDs. We compared the rate of AED-related PSEs in patients newly started on the newer AEDs both before and after controlling for non-AED predictors of PSEs. RESULTS: Overall, 221 of 1394 (16%) patients experienced PSEs. The average rate of AED-related PSEs for a single AED was 8.4%, with 6.1% resulting in dosage change and 4.3% resulting in AED discontinuation. Significantly fewer PSEs were attributed to gabapentin (n=160, 0.6% incidence, P<0.001) and lamotrigine (n=547, 4.8% incidence, P<0.001), and significantly more PSEs were attributed to levetiracetam (n=521, 15.7% incidence, P<0.001; 8.8% discontinued LEV because of PSEs). Vigabatrin, felbamate, and oxcarbazepine were associated with similarly low rates of PSEs in many analyses but with fewer of patients. Tiagabine was associated with high PSE rates (similar to those for levetiracetam), but was used much less commonly at our center. Intermediate rates of PSEs were attributed to topiramate and zonisamide (both nonsignificant). Psychiatric history was the most significant nondrug predictor of AED-related PSEs (PSEs occurred in 23% of patients with a psychiatric history vs 12% of patients without such a history, P<0.001). The relative rates of AED-related PSEs were similar when controlling for non-AED predictors and when analyzing only patients on monotherapy. CONCLUSIONS: There are significant differences between the newer AEDs in terms of their PSE profiles. Patients taking levetiracetan experience significantly more PSEs than average, and patients taking gabapentin and lamotrigine experience significantly fewer PSEs. Even with the medication with the highest rate of PSEs (levetiracetam), less than 10% of patients discontinued it because of PSEs. A past psychiatric condition is the most significant nondrug predictor of AED-related PSEs.

    Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Publishing Authors By Initials

    d weintraubD Weintraub,r buchsbaumR Buchsbaum,sr resorSR Resor,lj hirschLJ Hirsch,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Epilepsy & behavior : E&B

    VOLUME: 10

    Page Numbers: 105-10

    Journal Abbreviation:

    ISSN: 1525-5050

    DAY: 31

    MONTH: 10

    YEAR: 2006

    Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100892858

    Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.

    AFFILIATION: Department of Neurology, Columbia University Comprehensive Epilepsy Center, New York, NY, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Epilepsy Behav

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News